Insmed Newsroom

Evercore Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $75

Futu NewsSep 11 21:31

Barclays Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $90

Futu NewsSep 11 15:32

Barclays Sticks to Their Buy Rating for Insmed (INSM)

TipRanksSep 11 15:20

Stifel Maintains Insmed(INSM.US) With Buy Rating

Futu NewsSep 10 23:31

Insmed Maintains Competitive Edge Amid Lackluster Trial Results for Rival Drug BI 1291583

TipRanksSep 10 22:37

Insmed Analyst Ratings

BenzingaAug 29 19:52

HC Wainwright & Co. Reiterates Buy on Insmed, Maintains $90 Price Target

BenzingaAug 29 19:52

H.C. Wainwright Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $90

Futu NewsAug 29 18:31

Insmed's Brensocatib Poised for Market Leadership: A Buy Rating Amidst Unthreatening Competition

TipRanksAug 29 18:30

Buy Rating Affirmed for Insmed on Breakthrough Trials and Market Expansion Opportunities

TipRanksAug 13 22:09

Truist Financial Reaffirms Their Buy Rating on Insmed (INSM)

TipRanksAug 12 19:33

Insmed Analyst Ratings

BenzingaAug 12 19:15

Brensocatib Poised for Market Success: A Buy Rating for Insmed Amid Positive KOL Sentiment and Limited Competition

TipRanksAug 12 18:37

HC Wainwright & Co. Reiterates Buy on Insmed, Maintains $90 Price Target

BenzingaAug 12 18:37

TD Cowen Maintains Buy on Insmed, Raises Price Target to $98

BenzingaAug 10 01:47

Insmed (INSM) Receives a Buy From Morgan Stanley

TipRanksAug 9 21:49

Insmed Analyst Ratings

BenzingaAug 9 20:37

Insmed's Promising Outlook: Buy Rating Backed by Arikayce Performance and Brenso Launch Potential

TipRanksAug 9 19:31

Strong Arikayce Sales and Promising Clinical Advancements Bolster Buy Rating for Insmed

TipRanksAug 9 09:37

Insmed Analyst Ratings

BenzingaJul 13 01:04